Luo, Xiandong – Trademark Portfolio

Entity Type: 01

Luo, Xiandong owns a portfolio of 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as ANYDEAR, MINICOM, and MINICLOUD. Of these, 3 are registered. The portfolio spans 3 Nice Classification classes, led by Class 25 (Clothing) and Class 10 (Medical Apparatus). Headquartered in Guangdong.

No. 49, Sanzhai Vil. Fudong Vil Comm

Muge Town, Guangning County

Guangdong 526348 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MINICLOUD
MINICLOUD
Registered 2021
MINICOM
MINICOM
Registered 2021
ANYDEAR
ANYDEAR
Registered 2021

Trademark Classifications

Luo, Xiandong's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (1 filing)

Clothing, footwear, headgear

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

28
Toys & Sporting Goods (1 filing)

Games and playthings; gymnastic and sporting articles; decorations for Christmas trees

Frequently Asked Questions

How many trademarks does Luo, Xiandong have?

Luo, Xiandong has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Luo, Xiandong file in?

Luo, Xiandong files trademarks across 3 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 10 (Medical Apparatus), Class 28 (Toys & Sporting Goods). Class 25 covers clothing, footwear, headgear.

What are Luo, Xiandong's most well-known trademarks?

Luo, Xiandong's registered trademark portfolio includes well-known marks such as ANYDEAR, MINICOM, and MINICLOUD. These are among 3 currently registered trademarks in the portfolio.

What is Luo, Xiandong's trademark registration success rate?

Luo, Xiandong has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.